申请人:Thompson A. Lorin
公开号:US20060046984A1
公开(公告)日:2006-03-02
There is provided a series of novel substituted gamma-lactams of Formula (I)
or a stereoisomer; or a pharmaceutically acceptable salt thereof, wherein R
1
, R
2
, R
4
, R
5
and R
6
as defined herein, their pharmaceutical compositions and methods of use. These novel compounds inhibit the processing of amyloid precursor protein (APP) by β-secretase and, more specifically, inhibit the production of Aβ-peptide. The present disclosure is directed to compounds useful in the treatment of neurological disorders related to β-amyloid production, such as Alzheimer's disease and other conditions affected by anti-amyloid activity.
提供了一系列新型取代的γ-内酰胺,化学式为(I)或其立体异构体;或其药用盐,其中R1、R2、R4、R5和R6如本文所定义,它们的药用组合物和使用方法。这些新型化合物抑制β-分泌酶对淀粉样前体蛋白(APP)的加工,更具体地抑制Aβ肽的产生。本公开涉及对β-淀粉样蛋白产生相关的神经系统疾病的治疗有用的化合物,如阿尔茨海默病和其他受抗淀粉样活性影响的疾病。